EuroPCR Highlights: Interventions for Valvular Disease and Heart Failure

Find out why the Heart Team “won” this year’s Great Debate on opening TAVI to intermediate risk patients when we join S. Windecker, B. Prendergast and D. Tchetche as they discuss one of the central themes of EuroPCR 2016. Innovation and safety are key words in state of the art in mitral valve interventions or the role interventional cardiology and certain new devices could play in the treatment of Heart Failure… Join the discussion!

This video is supported by an educational grant from Edwards Lifesciences.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: